Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases
Drug Utilization Study on Diane-35 (and Generics) in Three European Healthcare Databases
The study objectives are to characterize new users of Cyproterone Acetate / Ethinylestradiol
 (CPA/EE) in 2011/2012 and in 2014 according to demographics, treatment characteristics,
 previous diagnosis of acne, hirsutism or other hyperandrogenic conditions, previous acne
 treatment and (concomitant) use of hormonal contraceptives identified in Healthcare Databases
 in the UK (THIN), the Netherlands (PHARMO) and Italy (HSD).
Inclusion Criteria:

 -  The study population will include all female patients registered in the investigated
 healthcare databases receiving CPA/EE in 2011 or 2012 (first run) or 2014 (second
 run), without a prescription of CPA/EE in the year prior to index date. Only patients
 with recorded history in the database of ≥ 365 days prior to index date will be
 included in the study.

 Exclusion Criteria:

 -  <365 days recorded history in the database prior to index date

 -  a prescription of CPA/EE in the year prior to index date